Products for Research Use Only
RegisterLogin

Suraxavir marboxil

CAT: 0804-HY-143744-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-143744-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cap-dependent endonuclease-IN-3 is a potent inhibitor of cap-dependent endonuclease (CEN) . Not only can Cap-dependent endonuclease-IN-3 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-3 has the potential for the research of influenza A and influenza B infection (extracted from patent WO2019141179A1, compound VI-1) [1].
CAS Number
2364589-86-4
Product Name Alternative
GP681; Cap-dependent endonuclease-IN-3
UNSPSC
12352005
Target
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cap-dependent-endonuclease-in-3.html
Solubility
10 mM in DMSO
Smiles
O=C1N2[C@](COC3(CC3)C2)([H])N([C@@]4([H])C5=CC=C(F)C(F)=C5CSC6=CC=CC=C64)N7C1=C(C(C=C7)=O)OCOC(OC)=O
Molecular Formula
C29H25F2N3O7S
Molecular Weight
597.59
References & Citations
[1]Li Chen, et al. Pyridone derivative, its composition and application as anti-influenza virus drug. Patent WO2019141179A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3

Related Products

CatalogName
HY-164927-01Tivoxavir marboxil
HY-143769Sebaloxavir marboxil
HY-109025-01Baloxavir marboxil
HY-109025R-01Baloxavir marboxil (Standard)
HY-132894-01Pixavir marboxilo

Alternative Products

CatalogName
B8453-10Baloxavir marboxil
RM-B011511-01Baloxavir Marboxil Impurity 11 (Baloxavir Marboxil Enantiomer)
A17088-500Baloxavir marboxil 500mg
A17088-100Baloxavir marboxil 100mg
A17088-10Baloxavir marboxil 10mg

Popular Products